Source document: https://docs-lawep.s3.us-east-2.amazonaws.com/1697752493673.pdf (Georgia)
The following announcement is made in accordance with DTR 5 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1.
Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii GEORGIA HEALTHCARE GROUP PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3.
Full name of person(s) subject to the notification obligation: iii 4.

Full name of shareholder(s) (if different from 3.

):iv 5.

Date of the transaction and date on which the threshold is crossed or reached: v 6.

Date on which issuer notified: 7.

Threshold(s) that is/are crossed or reached: vi, vii T. Rowe Price Associates, Inc. Bank of New York Mellon (FL) Bank of New York Mellon Bank, N.A.

JP Morgan Chase State Street Bank & Trust Co 08 April 2016 14 April 2016 5% 8.
Notified details: A: Voting rights attached to shares viii, ix Class/type of shares Situation previous to the triggering transaction Number of Shares Number of Voting Rights if possible using the ISIN CODE GB00BYSS4K11 Resulting situation after the triggering transaction Number of shares Direct Number of voting rights Direct xi Indirect xii % of voting rights x Direct Indirect 6,347,933 6,347,933 6,860,375 6,860,375 5.20% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial instrument Expiration date xiii Exercise/ Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted.
% of voting rights C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of financial instrument Exercise price Expiration date xvii Exercise/ Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 6,860,375 5.20% 9.
Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi T. Rowe Price Associates, Inc. (TRPA) serves as investment adviser, with dispositive and voting authority, to various institutional clients that own shares of Georgia Healthcare Group Plc, including the T. Rowe Price International Discovery Fund, Inc., which owns 4,932,042 shares.
Such shares are registered in the following name(s): Bank of New York Mellon (FL) – 97,928 Bank of New York Mellon Bank, N.A.

– 136,797 JP Morgan Chase – 6,483,208 State Street Bank & Trust Co. – 142,442 Proxy Voting: 10.

Name of the proxy holder: 11.

Number of voting rights proxy holder will cease to hold: 12.

Date on which proxy holder will cease to hold voting rights: 13.

Additional information: 14.

Contact name: Gary Greb, Vice President T. Rowe Price Associates, Inc. 15.
Contact telephone number: 001 410 345 2527